{"id":"W2005561360","doi":"10.1111/dom.12474","title":"Two dose‐ranging studies with <scp>PF</scp> ‐04937319, a systemic partial activator of glucokinase, as add‐on therapy to metformin in adults with type 2 diabetes","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"ca_institutions":"Golder Associates (Canada)","funders":"Pfizer","keywords":"Metformin; Glucokinase; Activator (genetics); Type 2 diabetes; Medicine; Internal medicine; Endocrinology; Diabetes mellitus; Cancer research; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001512184,0.0009372918,0.001635675,0.0004427681,0.0002591234,0.0007219315,0.0006498354,0.001365005,0.004618025],"category_scores_gemma":[0.001623534,0.0006024393,0.001843672,0.0004974017,0.0006845634,0.0006734176,0.000376411,0.002210723,0.0004899428],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004446215,"about_ca_system_score_gemma":0.0006238787,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005464207,"about_ca_topic_score_gemma":0.001665778,"domain_scores_codex":[0.9993272,0.000357955,0.00008016091,0.0000950726,0.00007137354,0.00006823232],"domain_scores_gemma":[0.9986275,0.0004299512,0.0003774946,0.0001142275,0.00009402894,0.0003567774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9425095,0.01137215,0.001529269,0.0007244673,0.00163079,0.00006184311,0.00006898453,0.0002940384,0.008118223,0.00006845356,0.0003782065,0.033244],"study_design_scores_gemma":[0.7608617,0.2283301,0.00657777,0.00005471679,0.00129247,0.0000898128,0.00003218306,0.0001390293,0.001718233,0.00007761249,0.0008024999,0.00002388711],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913361,0.004615943,0.000313179,0.000283585,0.0001413604,0.001361173,0.0004906161,0.00003338984,0.001424636],"genre_scores_gemma":[0.9918051,0.003259268,0.001184016,0.0006012438,0.0002364597,0.001136568,0.0006569784,0.000009148091,0.001111215],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004618025,"threshold_uncertainty_score":0.01544881,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01884958662028348,"score_gpt":0.2627396493139453,"score_spread":0.2438900626936618,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}